Rucaparib is an active pharmaceutical ingredient that functions as a PARP inhibitor. This compound is an azepinoindole derivative used in pharmaceutical manufacturing as a raw material for research and development applications.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Rucaparib camsylate
pharmaceutical raw material
Veliparib
pharmaceutical raw material
Sn-glycero-3-phosphocholine
pharmaceutical raw material
Bumetanide
pharmaceutical raw material
(6a,11b,16a,17a)-6,9-Difluoro-11,17-dihydroxy-16-methyl-3-oxoandrosta-1,4-diene-17-carboxylic acid
pharmaceutical raw material
GGFG-Eribulin
pharmaceutical raw material
The international HS code for 8-Fluoro-2-(4-((methylamino)methyl)phenyl)-1,3,4,5-tetrahydro-6H-azepino(5,4,3-cd)indol-6-one (CAS 283173-50-2) is 2933.79.
2933.79
2933 79 00
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
6-fluoro-2-[4-(methylaminomethyl)phenyl]-3,10-diazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-9-one
HMABYWSNWIZPAG-UHFFFAOYSA-N
CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=C3C(=CC(=C4)F)N2
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.